Vimarsana
Biggest News Aggregation in the World

Page 17 - Trustworthy Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trustworthy Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trustworthy Development Today - Breaking & Trending Today

Biden Artificial Intelligence Executive Order Action Tracker - Vimarsana News

Biden Artificial Intelligence Executive Order Action Tracker

Mayer Brown's Biden Artificial Intelligence Executive Order Action Tracker is designed to help companies keep track of the actions taken by the Biden Administration under the AI EO, as well as those...

PTO on AI Inventorship: Will the Real Natural Human Inventors Please Stand Up? - Vimarsana News

PTO on AI Inventorship: Will the Real Natural Human Inventors Please Stand Up?

On February 13, 2024, the US Patent & Trademark Office (PTO) issued a notice with examination guidance and request for comment regarding inventorship…

Artificial Intelligence Briefing: House Launches Bipartisan AI Task Force | Faegre Drinker Biddle & Reath LLP - Vimarsana News

Artificial Intelligence Briefing: House Launches Bipartisan AI Task Force | Faegre Drinker Biddle & Reath LLP

The House of Representatives aims to keep the U.S. at the leading edge of AI policy and innovation with a bipartisan task force while the FTC considers expanding a rule to crack down on...

USPTO: AI Use In Invention Process Does Not Foreclose Patentability - Trademark - Vimarsana News

USPTO: AI Use In Invention Process Does Not Foreclose Patentability - Trademark

In accordance with an executive order on the use of artificial intelligence ("AI"), the United States Patent and Trademark Office ("USPTO") published guidance on February 13, 2024...

Source: mondaq.com
FDA 2023-24: A Look Back & A Peek Forward | Polsinelli - Vimarsana News

FDA 2023-24: A Look Back & A Peek Forward | Polsinelli

Most years are eventful for businesses regulated by the US Food and Drug Administration (“FDA”), and 2023 was no exception. 2024 promises more of the same – it being a Presidential...